AIM
BMY icon

Avity Investment Management’s Bristol-Myers Squibb BMY Stock Holding History

Avity Investment Management’s Portfolio BMY Stock Details BMY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-3,741
Closed -$239K – 88
2023
Q2 		$239K Sell
3,741
-49,609
-93% -$3.33M 0.02% 84
2023
Q1 		$3.7M Sell
53,350
-19,137
-26% -$1.35M 0.36% 38
2022
Q4 		$5.21M Sell
72,487
-26,050
-26% -$1.96M 0.53% 35
2022
Q3 		$7M Sell
98,537
-101,667
-51% -$7.37M 0.76% 32
2022
Q2 		$15.4M Sell
200,204
-66,879
-25% -$5.09M 1.58% 30
2022
Q1 		$19.5M Buy
267,083
+16,555
+7% +$1.11M 1.71% 29
2021
Q4 		$15.6M Sell
250,528
-44,713
-15% -$2.62M 1.22% 32
2021
Q3 		$17.5M Buy
295,241
+4,205
+1% +$277K 1.47% 31
2021
Q2 		$19.4M Buy
291,036
+7,605
+3% +$496K 1.64% 30
2021
Q1 		$17.9M Buy
283,431
+24,282
+9% +$1.51M 1.62% 29
2020
Q4 		$16.1M Buy
259,149
+52,550
+25% +$3.23M 1.53% 30
2020
Q3 		$12.5M Buy
206,599
+130,435
+171% +$7.85M 1.3% 31
2020
Q2 		$4.48M Buy
76,164
+69,685
+1,076% +$4.17M 0.5% 34
2020
Q1 		$361K Hold
6,479
– – 0.05% 47
2019
Q4 		$416K Hold
6,479
– – 0.05% 54
2019
Q3 		$329K Sell
6,479
-1,500
-19% -$70.5K 0.04% 59
2019
Q2 		$362K Buy
7,979
+300
+4% +$14K 0.04% 56
2019
Q1 		$366K Sell
7,679
-1,020
-12% -$50.8K 0.04% 56
2018
Q4 		$452K Sell
8,699
-100
-1% -$5.37K 0.06% 47
2018
Q3 		$546K Buy
8,799
+120
+1% +$7.12K 0.06% 48
2018
Q2 		$480K Buy
8,679
+950
+12% +$51.3K 0.06% 47
2018
Q1 		$489K Buy
7,729
+100
+1% +$6.43K 0.06% 48
2017
Q4 		$468K Buy
7,629
+1,590
+26% +$99.5K 0.06% 51
2017
Q3 		$385K Hold
6,039
– – 0.05% 53
2017
Q2 		$336K Hold
6,039
– – 0.05% 58
2017
Q1 		$328K Sell
6,039
-7
-0.1% -$384 0.05% 60
2016
Q4 		$353K Sell
6,046
-325
-5% -$17.8K 0.05% 55
2016
Q3 		$317K Buy
6,371
+1,250
+24% +$80.3K 0.05% 55
2016
Q2 		$377K Buy
+5,121
New +$362K 0.06% 54

Other funds holding BMY

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $935B AUM

Avity Investment Management's BMY Position: Q3 2023 in Review

Avity Investment Management sold out of Bristol-Myers Squibb (BMY) in Q3 2023, closing a stake of 3,741 shares — an estimated $239K sold.

Avity Investment Management first reported a position in BMY in Q2 2016 and held it in 29 quarters. The position peaked at $19.5M in Q1 2022. 2,387 funds tracked by Wall St. Rank hold BMY as of Q3 2023.

  • Avity Investment Management reported no remaining Bristol-Myers Squibb position as of Q3 2023 after selling out during the quarter.
  • Avity Investment Management sold 3,741 Bristol-Myers Squibb shares in Q3 2023, an estimated $239K.
  • Avity Investment Management first reported a position in Bristol-Myers Squibb in Q2 2016 and held it in 29 quarters.
  • Avity Investment Management's Bristol-Myers Squibb position peaked at $19.5M in Q1 2022.
  • 2,387 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q3 2023.

Based on Avity Investment Management's 13F filing for Q3 2023, filed 18 Oct 2023.